NASDAQ$AZTA
Azenta Inc · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Briefing
Azenta reported mixed Q4 2024 results with revenue down slightly but growth in core segments and margin expansion.
Azenta's Q4 2024 revenue was $170 million, a 1% decrease year-over-year. However, the combined Sample Management Solutions and Multiomics businesses grew 5% organically. The company reported a diluted EPS from continuing operations of ($0.10) and a non-GAAP diluted EPS of $0.18. They are pursuing the sale of B Medical Systems.
- Revenue decreased by 1% year-over-year to $170 million.
- Combined Sample Management Solutions and Multiomics businesses grew 5% organically.
- Non-GAAP diluted EPS was $0.18, compared to $0.13 in the prior year.
- The company announced plans to sell B Medical Systems.
Headline financials
Revenue & EPS history
Azenta · Revenue · Quarterly
$170M
Forward guidance
Azenta expects total organic revenue growth in the range of 3% to 5% for fiscal year 2025, excluding B Medical Systems. Adjusted EBITDA margin expansion is expected to be approximately 300 basis points relative to fiscal 2024.
Tailwinds
- Total organic revenue is expected to grow in the range of 3% to 5% relative to fiscal 2024.
- Adjusted EBITDA margin expansion is expected to be approximately 300 basis points relative to fiscal 2024.
- Focus on core revenue growth in Sample Management Solutions and Multiomics businesses.
- Commitment to meaningfully expand margins.
- Renewed focus on free cash flow.
Headwinds
- Azenta does not provide forward-looking guidance on a GAAP basis.
- Inherent difficulty in accurately forecasting the occurrence and financial impact of the various adjusting items.
- Adjustments include transformation costs, restructuring charges, costs related to acquisitions and divestitures costs, governance-related matters, goodwill and intangible impairments, and other gains and charges.
- These adjustments are not representative of the normal operations of the business.
- Company is unable to provide a quantitative reconciliation of forward-looking non-GAAP measures to the most directly comparable forward-looking GAAP measure, without unreasonable effort.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+0.4%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+22.4%
Q4 2025
Best reaction
-23.4%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -21.6% | -21.0% | -6.1% | |
| Q1 2026 | -23.4% | -19.3% | -34.2% | |
| Q4 2025 | +22.4% | +20.9% | +14.8% | |
| Q2 2025 | -0.7% | +11.3% | +13.1% | |
| Q1 2025 | +3.4% | -8.6% | -16.0% | |
| Q4 2024 | -2.9% | -9.4% | +0.2% | |
| Q3 2024 | -4.9% | -1.1% | -15.4% | |
| Q2 2024 | -4.8% | -6.9% | -2.1% | |
| Q1 2024 | -4.0% | -1.2% | -2.0% | |
| Q4 2023 | +14.6% | +16.1% | +27.2% | |
| Q3 2023 | +21.8% | +18.4% | +11.0% | |
| Q2 2023 | -19.8% | -11.1% | +0.0% | |
| Q1 2023 | -20.8% | -22.2% | -29.7% | |
| Q4 2022 | +15.8% | +17.5% | +25.8% | |
| Q3 2022 | -10.3% | -8.7% | -23.8% | |
| Q2 2022 | -4.0% | +5.6% | +8.9% | |
| Q1 2022 | +5.6% | -3.1% | -7.0% | |
| Q4 2021 | -7.6% | -7.1% | -16.7% | |
| Q3 2021 | -4.0% | -4.0% | -3.5% | |
| Q2 2021 | -7.3% | -7.1% | -2.9% | |
| Q1 2021 | -2.8% | -0.3% | -4.2% | |
| Q4 2020 | +9.7% | +12.8% | +19.9% | |
| Q3 2020 | +17.8% | +21.2% | +13.2% | |
| Q2 2020 | -15.4% | -12.3% | -3.9% | |
| Q1 2020 | -1.4% | +6.7% | -15.1% | |
| Q4 2019 | +7.8% | +5.5% | -7.7% | |
| Q3 2019 | -15.7% | -17.0% | -14.1% | |
| Q2 2019 | +18.5% | +23.4% | +15.6% | |
| Q1 2019 | +0.9% | -5.3% | -0.4% | |
| Q4 2018 | -11.6% | -10.9% | -13.6% | |
| Q3 2018 | -7.2% | -5.8% | +22.3% | |
| Q2 2018 | +8.4% | +12.5% | +31.4% | |
| Q1 2018 | -3.4% | -9.5% | -2.4% | |
| Q4 2017 | -23.3% | -21.2% | -28.8% | |
| Q3 2017 | -8.1% | +0.9% | +6.6% | |
| Q2 2017 | +6.0% | +9.4% | +16.3% | |
| Q1 2017 | +16.9% | +20.6% | +20.0% | |
| Q4 2016 | +7.7% | +11.7% | +20.1% | |
| Q3 2016 | -3.3% | -5.4% | -1.7% | |
| Q2 2016 | -7.3% | — | — | |
| Q1 2016 | -1.7% | — | — | |
| Q4 2015 | -0.2% | — | — | |
| Q3 2015 | +11.2% | — | — | |
| Q2 2015 | -0.5% | — | — | |
| Q1 2015 | -5.1% | — | — | |
| Q4 2014 | +6.0% | — | — | |
| Q3 2014 | +2.7% | — | — | |
| Q2 2014 | +1.1% | — | — | |
| Q1 2014 | -1.3% | — | — | |
| Q4 2013 | +2.9% | — | — | |
| Q3 2013 | -4.0% | — | — | |
| Q2 2013 | +2.7% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.3% | — | — | |
| Q3 2012 | -13.8% | — | — | |
| Q2 2012 | -1.1% | — | — | |
| Q1 2011 | +7.2% | — | — | |
| Q1 2012 | +7.2% | — | — | |
| Q4 2009 | +2.8% | — | — | |
| Q2 2011 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q4 2010 | -0.1% | — | — | |
| Q3 2010 | -0.1% | — | — | |
| Q3 2011 | -0.1% | — | — | |
| Q2 2010 | -6.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro